AMAKEM
ActiveSummary
AMAKEM has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €421,110 and a net result of -€5,969. Equity is shrinking by about 3.3% per year across the filed financial years. Its solvency ranks better than 95% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Board 4
Permanent representatives 3
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| E.A.ENTREPRISES |
|
| LRM Beheer |
|
| ORRIX MANAGEMENT |
|
| Ortix managementfrom an act |
|
The directors' other companies
2 other companies of this director went bankrupt (2025, 2026).
- Hammer-IMS bankruptcy on 15-07-2026Official Gazettemandate 2022 to 2023
- FOx Biosystems bankruptcy on 23-01-2025Official Gazettemandate since 2024
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it. Only boards we have read from the Gazette; other companies may still be missing.
Owners and capital
Owners
4 ownersOwners 4
-
26.75%
-
18.86%
-
15.24%
-
12.06%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 29-02-2024 Capital reduction of €23,342,579.50 · to €420,515